ARCHIVES

European Commission Approves Subcutaneous Rituximab

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Final Issue Of 1992

December 11, 1992

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012